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The prevalence of obesity in older people is the
leading cause of metabolic syndromes. Central
neurons serving as homeostatic sensors for body-
weight control include hypothalamic neurons that
express pro-opiomelanocortin (POMC) or neuropep-
tide-Y (NPY) and agouti-related protein (AgRP). Here,
we report an age-dependent increase of mammalian
target of rapamycin (mTOR) signaling in POMC
neurons that elevates the ATP-sensitive potassium
(KATP) channel activity cell-autonomously to silence
POMC neurons. Systemic or intracerebral adminis-
tration of the mTOR inhibitor rapamycin causes
weight loss in old mice. Intracerebral rapamycin infu-
sion into old mice enhances the excitability and neu-
rite projection of POMC neurons, thereby causing a
reduction of food intake and body weight. Con-
versely, young mice lacking the mTOR-negative
regulator TSC1 in POMC neurons, but not those lack-
ing TSC1 in NPY/AgRP neurons, were obese. Our
study reveals that an increase in mTOR signaling in
hypothalamic POMC neurons contributes to age-
dependent obesity.
INTRODUCTION
Obesity poses a growing risk for the middle-aged adult popula-
tion. This phenomenon may have different causes including
genetic predisposition, poor dietary habits, and sedentary life-
style. As the aging population increases, obesity has become
a global health issue especially in developed countries (Marcel-
lini et al., 2009). The increased prevalence of obesity among old
people has emerged as the leading cause of metabolic syn-
dromes such as type II diabetes, heart diseases, and stroke
(Mokdad et al., 2001). Hence, weight control for the elderly pop-
ulation is not just a cosmetic procedure; it will dramaticallyreduce the risk of obesity-related comorbidities, which are
commonly associated with the aging process (Marcellini et al.,
2009). As the obesity and diabetes epidemics continue to rise
and the global population ages further, greater efforts are being
devoted to understanding the mechanisms of age-dependent
metabolic disorders (Freedman et al., 2002).
The hypothalamus is the control center for food intake and
body weight (Berthoud and Morrison, 2008; Hill et al., 2008).
Among hypothalamic neurons, the POMC neurons that express
pro-opiomelanocortin (POMC) and secrete an anorexic neuro-
peptide melanocyte-stimulating hormone (a-MSH), a proteolytic
product of POMC, and the NPY/AgRP neurons that express and
secrete the orexic neuropeptides Neuropeptide-Y (NPY) and
agouti-related protein (AgRP), are the key players in regulating
food intake and energy homeostasis (Elias et al., 1998). Defects
of this POMC-NPY/AgRP circuit cause serious abnormality in
food intake and body-weight control (Elmquist, 2001). Notwith-
standing our knowledge about this hypothalamic circuit in the
regulation of body weight in the normal physiological setting,
how this circuit might be altered with aging is an open question.
The mammalian target of rapamycin (mTOR) is a serine/
threonine kinase that integrates nutrients and hormonal signals
to control cell growth and proliferation (Wullschleger et al.,
2006). The mTOR activity is negatively regulated by the tuberous
sclerosis complex (TSC) composed of TSC1 and TSC2; AKT
activates mTOR by inhibiting TSC (Wullschleger et al., 2006).
The mTOR inhibitor rapamycin, a Federal Drug Administration-
approved drug for patients with organ transplant, has been
considered for treatment of psychiatric disorders and metabolic
disorders, and as a promising longevity-enhancing drug (Harri-
son et al., 2009). In addition to extending life span, reducing
mTOR activity may improve symptoms in neurodegenerative
diseases associated with aging, such as Alzheimer’s disease
and Parkinson’s disease. This beneficial effect of reducing
mTOR signaling might further improve the quality of life of the
aging population (Garelick and Kennedy, 2011). Given that
adult-onset obesity could result from hypothalamic neurodegen-
eration (Ryu et al., 2008; Xu et al., 2005) and leptin, an adipostatic
hormone secreted by white adipocytes, fails to augment energy
expenditure in older rodents, indicating leptin signaling may beNeuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc. 425
Figure 1. POMC Neurons in Old Mice Are Electrically Silent
(A and B) Representative current clamp recording traces of POMC neurons
from young (1 month old) mice (A) or aged (12 months old) (B) mice are shown
with the same scale. Dash lines represent 0 mV. Whereas POMC neurons from
young mice fired action potentials repeatedly (A), POMC neurons from aging
mice were silent (B).
(C–F) Basic biophysical characteristics of POMC neurons from 1-, 6-, 12-, and
18-month-old mice. (C) POMC neurons from mice that were 6 months old or
older had more hyperpolarized resting membrane potential as compared to
POMC neurons from 1-month-old young mice (p < 0.05, one-way ANOVA with
Bonferroni post hoc test with p < 0.05 for 1 month versus 6- and 18-month-old
mice; n = 27, 8, 7, and 21 neurons for 1-, 6-, 12-, and 18-month-old mice,
respectively). (D) POMC neurons from older mice had significantly reduced
action potential firing rates as compared to POMC neurons from 1-month-old
young mice (p < 0.05 one-way ANOVA with Bonferroni post hoc test with p <
0.05 for 1-month versus 6- and 18-month-old mice; n = 27, 8, 7, and 21
neurons for 1-, 6-, 12-, and 18-month-old mice, respectively). (E) POMC
neurons from 18-month-old mice were significantly larger as revealed by
membrane capacitance measurements (p < 0.05 one-way ANOVA with Bon-
ferroni post hoc test with p < 0.05 for 1-month versus 18-month-old mice; n =
28, 8, 6, and 21 neurons for 1-, 6-, 12-, and 18-month-old mice, respectively).
(F) The input resistance was significantly reduced in POMC neurons from older
mice (p < 0.05 one-way ANOVA with Bonferroni post hoc test with p < 0.05 for
1 month versus all age groups; n = 25, 7, 9, and 21 neurons for 1-, 6-, 12-, and
18-month-old mice, respectively).
See Figure S1 for the growth chart and ACTH immunostaining of GFP-positive
POMC neurons from POMC-GFP mice, and examples of robust firing of
hypothalamic neurons without GFP expression in old POMC-GFP transgenic
mice. Error bars indicate SEM.
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Rapamycin Ameliorates Obesity in Aged Miceattenuated with aging (Li et al., 1998), we wondered whether
age-dependent obesity might be associated with leptin resis-
tance due to hyperactive mTOR signaling in the hypothalamic
neuronal circuit. In particular, whereas in young mice only
10% of POMC neurons show active mTOR signaling and this426 Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc.fraction is increased to 18% upon leptin stimulation (Reed
et al., 2010), we wondered whether mTOR signaling is increased
in POMC neurons of aging mice. If so, suppressing this exces-
sive mTOR signaling via rapamycin administration may reestab-
lish the hypothalamic circuit and ameliorate age-dependent
obesity.
In this study, we have found that mTOR signaling is elevated in
the hypothalamic POMC neurons of old mice, causing silencing
of these neurons due to upregulation of KATP channel activity
accompanied with an aging-associated expression of the
Kir6.2 pore-forming subunit of KATP channels. In support of the
critical role of enhanced mTOR signaling in causing obesity,
removal of themTOR-negative regulator TSC1 in POMC neurons
of young mice elevated KATP channel activity, leading to silenc-
ing of POMC neurons and obliteration of leptin-induced release
of the anorexic hormone a-MSH. Whereas TSC1 deletion in
POMC neurons resulted in obesity of young mice, TSC1 deletion
in NPY/AgRP neurons had no effect on neuronal excitability or
body weight. Remarkably, infusion of the mTOR inhibitor rapa-
mycin into the brain of aging mice caused a reduction of body
weight. This intracerebral rapamycin infusion reduced food
intake without altering the blood glucose level. It also sup-
pressed KATP channel activity to increase repetitive firing of
POMC neurons, and expanded the POMC neuronal projection
into the paraventricular nucleus (PVN) involved in controlling
food intake and body weight. Taken together with our finding
that systemic rapamycin injection also reduces body weight of
old mice, this study raises the prospect of potential therapeutic
application of rapamycin to reduce midlife obesity.
RESULTS
POMC Neurons of Aged Mice Are Silent
Studies of POMC neurons from young rodents (typically < 3
months old) have shown that these neurons fire action poten-
tials repeatedly so as to cause a-MSH secretion; elimination of
action potential firing in POMC neurons abolishes a-MSH secre-
tion (Bunel et al., 1990). It is an open question whether POMC
neurons are still active in older rodents, which tend to display
obesity and increased-adiposity. Our recording of green fluores-
cent protein (GFP)-labeled POMC neurons from transgenic
mouse hypothalamic slices revealed that POMC neurons from
young (1 month old) mice were electrically active (Figures 1A
and 1D). In contrast, POMC neurons from aging (>6 months
old) mice, which had gained more weight (Figure S1C available
online), were silent (Figures 1B and 1D). As control for the health
of brain slices from aging mice, recordings from neurons without
GFP labeling from 12-month-old POMC-GFP mice revealed that
these neurons fired action potentials repeatedly, and some dis-
played rhythmic bursting characteristic of tuberoinfundibular
neurons in the arcuate nucleus (Figures S1A and S1B) (Lyons
et al., 2010). By surveying four different age groups of mice,
we found a significant reduction of input resistance of POMC
neurons from 6-, 12-, or 18-month-old mice as compared to
those from 1-month-old mice (p < 0.05 one-way ANOVA with
Bonferroni post hoc test) (Figure 1F), leading to a reduction of
action potential firing (Figure 1D). This silencing of POMC
neuronal activity was accompanied with a more hyperpolarized
Figure 2. Increased KATP Channel Activity
Silences POMC Neurons in Old Mice
(A) Blocking transmitter receptors with 10 mM
DNQX, an AMPA receptor antagonist, and 50 mM
picrotoxin (Pic), a GABAA receptor antagonist, did
not alter the resting membrane potential of POMC
neurons from young (1 month old) mice.
(B) DNQX and Pic abolished postsynaptic
potentials (arrows) without affecting the resting
membrane potential of POMC neurons (from
6-month-old mice) that remained silent. Further
addition of 10 mM glibenclamide, a specific KATP
channel blocker, significantly depolarized the
resting membrane potential and triggered spon-
taneous action potential firing.
(C) Statistical analysis of the effect of DNQX plus
Pic on the resting membrane potentials of young
(1month old, data sets on the left; n = 14) and older
(6 months old, data sets on the right; n = 8) mice.
Glibenclamide (10 mM) significantly depolarized
the silenced POMC neurons from 6-month-old
mice (ANOVA with Bonferroni post hoc test with
p < 0.05 for glibenclamide vs. other two groups).
(D) Left: A representative current clamp recording
of a POMC neuron from a young (1 month old)
mouse. Right: mRNA expression profiling of the
POMC neuron with its firing patterns shown on the
left; this single-cell RT-PCR analysis verified that
this neuron contained mRNA for POMC but not NPY, and further showed that it had mRNA for SUR1, an auxiliary KATP channel subunit, but lacked mRNA for the
KATP channel pore-forming subunit Kir6.1 or Kir6.2.
(E) Left: A representative current clamp recording of a POMC neuron from an old (12 month old) mouse. Right: mRNA expression profiling of the POMC neuron
with its recordings shown on the left; this single-cell RT-PCR analysis confirmed that this neuron containedmRNA for POMCbut not NPY, and further showed that
it expressed mRNA for both KATP channel subunits SUR1 and Kir6.2.
(F) Statistical analysis of Kir6.2 expression in young (1 month old; top pie chart; n = 11) and old (12 months old; bottom pie chart; n = 7) mice. A significantly larger
fraction of POMC neurons from oldmice showed a strong expression of Kir6.2, the pore-forming subunit of KATP channel, as compared with POMC neurons from
young mice (p < 0.05, Fisher’s exact test).
See Figure S2 for high mTOR activity of NYP/AgRP neurons from young mice. Error bars indicate SEM.
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capacitance, which provides a measure of the cell surface
area, was significantly increased in POMC neurons from 18-
month-old mice (Figure 1E).
POMC neurons in the arcuate nucleus receive multiple
synaptic inputs and display synaptic plasticity (Liu et al., 2012)
in response to physiological changes (Dicken et al., 2012; Pinto
et al., 2004). To ask whether synaptic plasticity may contribute to
the POMC neuron silencing in aged mice, we applied the gluta-
mate receptor antagonist DNQX (10 mM) and the GABA receptor
antagonist picrotoxin (50 mM) to the bath solution. Blocking these
transmitter receptors did not affect the resting potential or
reduce action potential firing of POMC neurons from young
(1 month old) mice (Figures 2A and 2C), nor did the antagonists
for these transmitter receptors alter the resting potential of the
silent POMC neurons from older (6 months old) mice (Figures
2B and 2C). Interestingly, glibenclamide, a specific KATP channel
blocker, induced significant depolarization and caused these
silent POMC neurons from aged mice to fire action potentials
even in the presence of the transmitter receptor antagonists
(Figures 2B and 2C). To test for the possibility that POMC
neurons from old mice have increased expression of KATP chan-
nels composed of the pore-forming subunit Kir6.2 (KCNJ11) and
the auxiliary sulfonylurea receptor subunit SUR1, we performedsingle-cell RT-PCR of POMC neurons from young mice (Fig-
ure 2D) and old mice (Figure 2E). We found an age-dependent
upregulation of Kir6.2 but not SUR1 mRNA (Figures 2D–2F).
Thus, aging is accompanied with Kir6.2 expression and KATP
channel-mediated silencing of POMC neurons.
mTOR Signaling Is Elevated in POMC Neurons of Aged
Mice
Previous studies have shown that increased mTOR activity
causes hypertrophy in numerous cell types including neurons
(Meikle et al., 2008). Given the suggestion that aging brains
may have elevated mTOR activity (Garelick and Kennedy,
2011), we wondered whether the hypertrophy of POMC neurons
in aged mice (Figure 1E) might be caused by increased mTOR
signaling in POMC neurons. Consistent with previous findings
of low mTOR activity in POMC neurons from young mice (Reed
et al., 2010; Villanueva et al., 2009), our immunostaining of hypo-
thalamic sections from the POMC-GFP transgenic mice with
antibody against GFP to label POMC neurons and antibody
against phospho-S6 (p-S6), an endogenous reporter of mTOR
activity, revealed that only a small fraction of the GFP-labeled
POMC neurons in 1-month-old mice showed phospho-S6
immunoreactivity (Figures 3A–3F), unlike NPY/AgRP neurons
that displayed robust mTOR signaling in young mice (Figure S2).Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc. 427
Figure 3. mTOR Signaling Is Upregulated in POMC Neurons from
Aged Mice
(A) Phosphorylated S6 (red, p-S6) (A, D, G, and J), a downstream effector of
mTOR and hence a reliable endogenous reporter for mTOR activity, in POMC-
GFP neurons (green, B, E, H, and I) from 12-month-old mice (bottom panels,
G–L) was at much higher levels than those from 1-month-old mice (A–F). (C),
(F), (I), and (L) show the merged images of p-S6 and GFP. A significantly
greater fraction of POMC-GFP neurons from old mice showed p-S6 staining
indicative of mTOR signaling (G–L). (D) to (F) and (J) to (L) are higher magnifi-
cation images corresponding to areas in the white squares shown in (A) to (C)
and (G) to (I), respectively. (M) Compared to POMC neurons in young mice,
a larger fraction of hypothalamic POMC neurons from old mice were positive
for p-S6 (p < 0.01, Student’s t test; five mice for each age group), indicative of
increased mTOR signaling. Scale bars are 100 mm for (A)–(C) and (G)–(I), and
50 mm for (D)–(F) and (J)–(L). In contrast to POMC neurons, NPY/AgRP neurons
displayed high levels of mTOR signaling in young (1 month old) mice (Fig-
ure S2). Error bars indicate SEM.
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428 Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc.In contrast, the mTOR activity as indicated by phospho-S6
immunoreactivity was significantly elevated in POMC neurons
of 12-month-old mice (Figures 3G–3M).
Genetic Manipulation to Increase mTOR Activity in
POMC Neurons Causes Obesity in Young Mice
Given that POMC neurons and NPY/AgRP neurons are the two
major appetite-controlling neurons in the hypothalamus, we
tested whether obesity could be induced by activating mTOR
signaling via conditional knockout of its upstream negative regu-
lator TSC1 (Meikle et al., 2008) in either POMC neurons (Figure 4)
or NPY/AgRP neurons (Figures 4 and S3). Consistent with
a previous study (Mori et al., 2009), we found deleting Tsc1 in
POMC neurons via Pomc-cre (Figure S4) but not in NPY/AgRP
neurons via Agrp-cre caused obesity (Figures 4A and 4B). More-
over, we found that TSC1 is essential for maintaining the ex-
citability of POMC neurons but not NPY/AgRP-neurons; condi-
tional knockout of Tsc1 in POMC neurons silenced these
neurons (Figure 4C), which could be induced to fire action poten-
tial via current injection (Figure S4), whereas conditional
knockout of Tsc1 in NPY/AgRP neurons had no effect on their
firing pattern (Figure 4C), resting membrane potential (Figure 4G)
or neuronal size (Figure 4E). Recapitulating features of POMC
neurons in aged mice (Figure 1), removal of the mTOR-negative
regulator TSC1 in POMC neurons resulted in hypertrophic soma
(Figure 4D), hyperpolarized resting membrane potential (Fig-
ure 4F) and reduced excitability (Figure 4H). Since the PI3K
signaling pathway has been proposed to silence POMC neurons
through activation of KATP channels (Plum et al., 2006) andmTOR
is downstream of PI3K in the signaling pathway, we wondered
whether the elevated mTOR signaling caused silencing of
POMC neurons by upregulating their KATP channel activity. To
test this possibility, we dialyzed the neuron under patch-clamp
whole-cell recording with an internal solution containing low
(0.5 mM) MgATP and treated the hypothalamic slice with
300 mM diazoxide, a KATP channel opener, to estimate the total
KATP channel activity in POMC neurons (Speier et al., 2005).
We found that removing the mTOR-negative regulator TSC1
indeed caused a significant increase of the total KATP channel
conductance (Figure 4I). These results lend further support to
the notion that elevation of mTOR signaling causes silencing of
POMC neurons mainly by increasing the KATP channel activity.
Previous studies indicate that hypothalamic KATP channels
regulate the blood glucose homeostasis: local application of
glibenclamide to the arcuate nucleus reduces the ability of
glucagon-like peptide 1 (GLP-1) to suppress hepatic gluconeo-
genesis (Sandoval, 2008), and hypothalamic KATP channel acti-
vation by infusing diazoxide, a specific KATP channel opener, to
the third ventricle suppresses glucose production thereby
lowering blood glucose (Pocai et al., 2005). Having found that
the increased mTOR signaling in POMC neurons from Pomc-
cre;Tsc1-f/f mice caused KATP activation (Figure 4I), we asked
whether the increased KATP currents in POMC neurons affect
glucose homeostasis. To our surprise, at 3 months of age, those
Pomc-cre;Tsc1-f/f mice that were about 50% heavier than
their heterozygous littermates (Figure 4B) did not show signs of
glucose intolerance; instead, they displayed a slight but signifi-
cant improvement in glucose tolerance based on intraperitoneal
Figure 4. Obesity Can Be Induced by Tar-
geted Deletion of Tsc1 in Hypothalamic
POMC Neurons, but Not in NPY/AgRP
Neurons
(A) Deleting Tsc1 in NPY/AgRP neurons did not
change body weight (p > 0.05, two-way repeated-
measures ANOVA; n = 14 for AgRP-cre;Tsc1-f/+
and n = 7 for AgRP-cre;Tsc1-f/f). The efficiency of
TSC1 removal was confirmed by immunostaining
to detect TSC1, the protein product of the Tsc1
gene. TSC1 were absent in NPY/AgRP neurons in
Agrp-cre;Tsc1-f/f;ai14 but not Agrp-cre;Tsc1-
f/+;ai14 mice (Figure S3).
(B) Deleting Tsc1 in POMC neurons significantly
increased body weight shortly after weaning (p <
0.001, two-way repeated-measures ANOVA; n =
10 for Pomc-cre;Tsc1-f/+ and n = 6 for Pomc-
cre;Tsc1-f/f).
(C–G) Representative current clamp traces from
1 months old (left to right): Agrp-cre;Tsc1-f/+,
Agrp-cre;Tsc1-f/f, Pomc-cre;Tsc1-f/+, Pomc-
cre;Tsc1-f/f mice (C). To fluorescently label NPY/
AgRP neurons, mice were crossed to the ai14
td-tomato line and NPY/AgRP neurons were
identified as red neurons. To fluorescently label
POMC neurons, mice were crossed to the
ZeG-GFP line and POMC neurons were identified
as green neurons. Activating mTOR by removing
Tsc1 increased the size of POMC neurons (p <
0.01, Student’s t test; n = 11 for Pomc-
cre;Tsc1-f/+ and n = 28 for Pomc-cre;Tsc1-f/f)
(D) but not NPY/AgRP neurons (p > 0.05,
Student’s t test; n = 4 for each group) (E). Acti-
vating mTOR by removing Tsc1 hyperpolarized
POMC neurons (p < 0.05, Student’s t test; n = 4
for Pomc-cre;Tsc1-f/+ and n = 7 for Pomc-cre;Tsc1-f/f) (F) but not NPY/AgRP neurons (p > 0.05, Student’s t test; n = 4 for each group) (G).
(H and I) Activating mTOR by removing Tsc1 reduced action potential firing (p < 0.01, Student’s t test; n = 4 for Pomc-cre;Tsc1-f/+ and n = 7 for Pomc-
cre;Tsc1-f/f) (H) and increased KATP currents in POMC neurons (p < 0.005, n = 12 for Pomc-cre;Tsc1-f/+ and n = 27 for Pomc-cre;Tsc1-f/f) (I).
(J and K) Intraperitoneal glucose tolerance tests of 3-month-old mice revealed an improved glucose tolerance of Pomc-cre;Tsc1-f/f mice compared to
heterozygous littermates (p < 0.05, Student’s t test, n = 6 for Pomc-cre;Tsc1-f/+ and n = 10 for Pomc-cre;Tsc1-f/f) (J), whereas Agrp-cre;Tsc1-f/+ and Agrp-
cre;Tsc1-f/f mice had comparable glucose tolerance (p > 0.05, Student’s t test, n = 11 for Agrp-cre;Tsc1-f/+ and n = 8 for Agrp-cre;Tsc1-f/f) (K).
See Figure S3 for control of Tsc1 conditional knockout from NPY/AgRP neurons and Figure S4 for control of Pomc-cre expression in POMC neurons and the
ability of silent POMC neurons from old mice to fire action potentials upon depolarization. Error bars indicate SEM.
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alterations of glucose tolerance in Agrp-cre;Tsc1-f/f mice
(Figure 4K).The Blunted Leptin Responsiveness of POMC Neurons
with Elevated mTOR Signaling Can Be Restored by
Blocking KATP Channels
Activation of mTOR in POMC neurons causes an attenuation of
sensitivity to leptin (Mori et al., 2009), which exerts its anorexic
effect by stimulating a-MSH secretion from POMC neurons
(Forbes et al., 2001). To test whether removal of TSC1 from
POMC neurons attenuates the ability of leptin to induce a-MSH
release, we measured a-MSH secretion from hypothalamic
tissue explants from Pomc-cre;Tsc1-f/+ mice and Pomc-
cre;Tsc1-f/f mice. Indeed, leptin failed to stimulate a-MSH secre-
tion from Pomc-cre;Tsc1-f/f hypothalamic explants (Figure 5),
while leptin applied together with 10 mM glibenclamide caused
an increase of a-MSH secretion (Figure 5). These results indicatethat the elevated KATP channel activity in POMC neurons lacking
TSC1 reduced the ability of leptin to stimulate a-MSH secretion
likely by silencing those POMC neurons.Intracerebral Rapamycin Infusion Causes Body-Weight
Loss in Aged Mice
AsmTOR signaling in POMCneuronswas significantly increased
in aged mice, we next tested whether suppressing mTOR
signaling by rapamycin can cause weight loss. Indeed, daily
intraperitoneal injection of rapamycin at 5 mg/kg of body weight,
the dose that has been shown previously to be effective for rapa-
mycin to cross blood-brain barrier without causing body-weight
change in young adult mice (Meikle et al., 2008) (Figure 6A),
reduced the body weight of 12-month-old mice (Figure 6B).
Because chronic systemic administration of rapamycin causes
glucose intolerance and hypoinsulinemia (Yang et al., 2012),
we infused rapamycin into the lateral ventricle in the brain
through an osmotic pump to avoid potential complications ofNeuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc. 429
Figure 5. Activating mTOR via Tsc1 Deletion Suppresses a-MSH
Secretion from Hypothalamic Tissue Explants Treated with Leptin
Basal levels of a-MSH secretion were comparable for explants from Pomc-
cre;Tsc1-f/+ (n = 5) and Pomc-cre;Tsc1-f/f (n = 3) mice. Leptin (50 nM) stim-
ulated a-MSH secretion from hypothalamic explants from Pomc-cre;Tsc1-f/+
mice (p < 0.05, Student’s t test; n = 5) but failed to trigger a-MSH secretion from
hypothalamic explants from Pomc-cre;Tsc1-f/f (p > 0.05, Student’s t test;
n = 4). Hypothalamic explants from both heterozygous and homozygous
littermates responded to 50 nM leptin administered together with 10 mM
glibenclamide with a-MSH secretion (p < 0.01 for Pomc-cre;Tsc1-f/+, n = 5; p <
0.05 for Pomc-cre;Tsc1-f/f, n = 4). See Figure S4 for control showing Pomc-cre
driving GFP expression in ACTH-positive neurons and control for the ability of
current injection to cause the silent POMC neurons from Pomc-cre;Tsc1-f/f
mice to fire action potential. Error bars indicate SEM.
Figure 6. Rapamycin Caused Weight Loss in Old—12 Months Old—
but Not Young—2 Months Old—C57B/6 Mice
(A and B) Mice received daily intraperitoneal injection of rapamycin (5 mg/kg)
or DMSO as vehicle-only control for 3 weeks (gray area; treatment) and
recovered for 2 weeks after rapamycin treatment (white area; recovery). Their
weekly averaged body weights were normalized to the initial value (as 100%)
before the onset of the treatment. Two-month-old mice receiving daily rapa-
mycin injection did not show any weight change (A), whereas 12-month-old
mice receiving rapamycin treatment showed a significant weight loss (p < 0.01
at third week; Student’s t test) (B). Ten mice were used for each group.
(C) Intracerebral rapamycin infusion caused weight loss in old (12 months old)
mice (p < 0.001, two-way repeated-measures ANOVA; n = 13 for each group).
(D) Mice receiving intracerebral infusion of either rapamycin or vehicle-only
control had similar glucose tolerance as revealed by the intraperitoneal
glucose tolerance test (p > 0.05, two-way repeated-measures ANOVA; n = 9
for control and n = 12 for rapamycin group).
(E) Mice receiving intracerebral rapamycin infusion showed a reduction in food
intake (p < 0.05, Student’s t test, n = 13 for each group).
See Figure S5 for the reduction of mTOR signaling in POMC-GFP transgenic
mice following intracerebral rapamycin infusion. Error bars indicate SEM.
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cin injection, chronic intracerebral infusion of rapamycin sig-
nificantly suppressed mTOR signaling in POMC neurons from
12-month-old mice (Figure S5). Moreover, intracerebral rapa-
mycin caused weight loss of 12-month-old mice (Figure 6C).
Those mice receiving intracerebral rapamycin infusion had
normal glucose tolerance (Figure 6D), indicating that rapamycin
had largely been confined within the central nervous system.
Thus, the weight loss was due to reduced mTOR signaling in
the central nervous system. Old mice receiving rapamycin
infusion into the brain also exhibited a reduction in food intake
(Figure 6E). Whereas rapamycin suppressed mTOR signaling
in NPY/AgRP neurons as well (Figure S2), it did not alter their
biophysical properties nor did it halt the action potential firing
(Figure S6), in contrast to the ability of rapamycin to enhance
the excitability of POMC neurons (Figure 7). These findings
provide further support for our hypothesis that the age-depen-
dent elevation of mTOR signaling inactivates POMC neurons to
cause excessive food consumption and body-weight gain,
raising the possibility that suppressing mTOR activity by rapa-
mycin can restore POMC neurons’ anorexic effect in exerting
weight control.
POMC Neurons from Old Mice Treated with Rapamycin
Are More Excitable
To directly assess the impact of intracerebral rapamycin infusion
on neuronal activity, we recorded from POMC neurons of
12-month-old mice that had rapamycin infused into the brain430 Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc.for 3 weeks. Similar to untreated old mice, POMC neurons
from control old mice receiving vehicle only from the pump
were silent (Figure 7A). Applying 10 mM glibenclamide to block
KATP channels restored neuronal excitability and action potential
firing (Figure 7A). In contrast, POMC neurons from old mice
receiving rapamycin infusion were more excitable and fired
action potentials repeatedly (Figure 7B) and had reduced KATP
channel activity (Figure 7C) and more depolarized resting
membrane potential (Figure 7D), thus recapitulating the features
of POMC neurons from young mice (Figure 1). Interestingly, we
found rapamycin not only restored the excitability but also
reduced the soma size of POMC neurons (Figure 7E), consistent
with previous reports of the mTOR effects on neuronal
morphology (Jaworski et al., 2005).
Figure 7. Intracerebral Rapamycin Infusion
Restores Hypothalamic POMC Neuronal
Excitability and Increased POMC Neurite
Projection
(A) Representative current clamp recording from
POMC neurons in mice receiving intracerebral
vehicle-only infusion. Application of 10 mM gli-
benclamide restored its excitability and caused
repetitive action potential firing. Intracerebral ra-
pamycin infusion significantly reducedmTOR level
in the POMC neurons (Figure S5).
(B) Representative current clamp recording from
POMC neurons in mice receiving intracerebral
rapamycin infusion. Unlike POMC neurons from
control old mice, POMC neurons from rapamycin-
treated old mice were highly excitable with re-
petitive action potential firing.
(C) Intracerebral rapamycin infusion significantly
reduced KATP currents in POMC neurons (defined
as glibenclamide-sensitive current) (p < 0.05,
Student’s t test; n = 5 for control and n = 7 for
rapamycin group).
(D) Intracerebral rapamycin infusion significantly
reduced the resting membrane potential in POMC
neurons (p < 0.05, Student’s t test; n = 11 for
control and n = 8 for rapamycin group).
(E) Intracerebral rapamycin infusion significantly
reduced POMC neuronal size as revealed by
capacitance measurement (p < 0.05, Student’s t
test; n = 6 for control and n = 9 for rapamycin
group). In contrast to POMC neurons, NPY/AgRP
neurons displayed high levels of mTOR signaling,
which was suppressed by daily intraperitoneal injection of 5 mg/kg rapamycin (Figure S2) but the basic biophysical characteristics of NPY/AgRP neurons were
unaltered (Figure S6).
(F–H) Representative images of GFP-positive POMC neurite projections in the PVN region from old (12 months old) mice that had received intracerebral vehicle-
only control (F) or rapamycin (G) infusion. Rapamycin-treated mice had a significantly greater amount of POMC neuronal projections in the PVN region as
compared to mice receiving vehicle-only control treatment. GFP-positive POMC neurite densities were quantified in (H) (p < 0.01, Student’s t test; n = 3 for each
group).
Scale bars in (F) and (G) are 100 mm. Error bars indicate SEM.
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to the PVN
Previous study has shown that removal of TSC1 from POMC
neurons reduces their projection to the target areas such as
the PVN thatmediates the control of food intake and bodyweight
(Mori et al., 2009). To quantify the POMC neuronal projection, we
measured theGFP-labeled POMCneurite density within the PVN
region from 12-month-old POMC-GFP transgenic mice that had
received intracerebral rapamycin infusion for 3 weeks. Indeed,
we found that mice with rapamycin infusion had more extensive
POMC neurites in the PVN region than control mice with vehicle-
only infusion (Figures 7F–7H).
DISCUSSION
Our study shows that mTOR signaling in hypothalamic POMC
neurons is elevated in aged mice, and we propose that this
heightened mTOR activity in POMC neurons contributes to
midlife obesity via two mechanisms: silencing POMC neurons
by activating KATP channels and reducing POMC neurite projec-
tion to its downstream target such as the PVN (Figure 8).
As POMCneurons exert their anorexic effect via a-MSH secre-
tion, and secretion of the anorexic a-MSH is highly dependenton the POMC neuronal excitability, modulating POMC neuron
electrical activity can have a dramatic effect on body weight.
Previous study has shown that nutrient overload such as high
fat diet silences the POMC neurons via activation of peroxisome
proliferator-activated receptor g (PPAR-g) thereby reducing re-
active oxygen species. Pharmacological block of PPAR-g re-
activates those silent POMC neurons and reduces food intake
(Diano et al., 2011). In our study of aging-dependent obesity,
we found that elevating mTOR signaling causes KATP channel
activation to silence POMC neurons (Figures 1, 2, 3, and 4). It
would be interesting to test whether the PPAR-g-mediated
neuronal silencing involves KATP channel activation.
KATP channels can be activated under injury such as hypoxia
(Ballanyi, 2004). Since brain slice preparations from old mice
are more fragile, we need to consider the possibility that neurons
with higher KATP channel density may have been more resistant
to the insults during the slice preparation. This possibility seems
unlikely for the following reasons. First, slices from old mice
treated with rapamycin had less KATP channel activity in POMC
neurons, which were also more excitable than POMC neurons
from old mice receiving vehicle-only infusion (Figures 7A and
7B). Second, recording from neurons without GFP expression,
which are hence not POMC neurons, in the arcuate nucleus ofNeuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc. 431
Figure 8. Summary of the Role of mTOR in Aging POMC Neurons
mTOR signaling in hypothalamic POMC neurons is relatively low in young
mice, those POMC neurons are electrically active and fire action potentials
repeatedly, and they have smaller soma with extensive neurite projections to
downstream targets such as PVN (left). In contrast, mTOR is elevated in aged
mice. This heightened mTOR activity silences POMC neurons by increasing
the KATP channel activity and reduces POMC neurite projection to its down-
stream target such as the PVN (right).
Neuron
Rapamycin Ameliorates Obesity in Aged Miceold POMC-GFPmice revealed that those neurons showed excit-
ability similar to that seen in young mice (Figure S1). These
controls provide validation for our conclusion that aging is asso-
ciated with reduced excitability of POMC neurons.
POMC neurons in the hypothalamic arcuate nucleus
are heterogeneous; they may exhibit different responses to
hormones and neurotransmitters. Thus, altering mTOR activity
will likely change the responsiveness of POMC neurons to
a number of different inputs (Williams et al., 2010). mTOR can
be activated by multiple ways such as branch-chained amino
acids (Cota et al., 2006), high-protein diet (Ropelle et al., 2008),
and leptin and insulin (Blouet et al., 2008). Previous studies
have found that short-term activation of mTOR by acute leucine
infusion (Cota et al., 2006) or through inhibiting the AMP-
activated protein kinase (AMPK), an endogenous mTOR sup-
pressor, reduces food intake and body weight (Ropelle et al.,
2008). However, other studies have shown that genetic manipu-
lation to increase mTOR activity by deleting the Tsc1 gene in
POMC neurons results in hyperphagic obesity in mice (Mori
et al., 2009). In our study, we found that sustained elevation of
mTOR activity due to conditional knockout of Tsc1 in POMC
neurons resulted in obesity of young mice (Figure 4). It takes at
least 2 weeks of rapamycin treatment to cause body-weight
loss. Moreover, chronic mTOR inhibition by intracerebral rapa-
mycin infusion suppressed appetite and reduced body weight
of old mice (Figure 6). It should be noted that POMC neurons
of young healthy mice rarely show any elevated mTOR activity
(Reed et al., 2010; Villanueva et al., 2009). Whereas leptin
increases mTOR activity in the basomedial hypothalamus
including the arcuate nucleus (Blouet et al., 2008; Cota et al.,
2006), leptin only modestly activates mTOR in POMC neurons
(Reed et al., 2010). Our finding of elevated mTOR signaling in
POMC neurons of old mice accounts for the effect of rapamycin
on midlife obesity and is further substantiated by recapitulating
the effects of elevated mTOR signaling on silencing POMC432 Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc.neuronal activity and causing body-weight gain in young mice
with conditional knockout of Tsc1 in POMC neurons.
It is important to consider various scenarios to reconcile the
discrepancy that short-term mTOR activation causes weight
loss while chronic activation of mTOR causes obesity. Depend-
ing on the dosage and duration, rapamycin may affect glucose
homeostasis in different ways (Blagosklonny, 2011b). Rapamy-
cin has also been proposed to have a hormetic effect on aging
and aging-related diseases (Blagosklonny, 2011a). Short-term
rapamycin transiently affects intracellular signaling activated
by nutrient overload; it does not affect body weight but abro-
gates the anorexia induced by nutrients such as leucine (Cota
et al., 2006). On the other hand, long-term rapamycin treatment
has a profound impact on neuronal morphology and functions.
Ion channels typically have slow turnover rates (Crane and Agui-
lar-Bryan, 2004), and any loss of neurite projection may require
a few days to be restored (Keck et al., 2011). Similarly, Mori
and colleagues have shown that activating mTOR in POMC
neurons by deleting the Tsc1 gene also results in enlarged
POMC neuron soma and reduced neurite projections to the
PVN, and chronic intraperitoneal injection of high doses of rapa-
mycin restores the projection (Mori et al., 2009). In our study, we
have identified that aging is one of the physiological factors to
activate mTOR in POMC neurons and the genetic activation of
mTOR in conditional knockout mice recapitulates the physiolog-
ical consequences of aging by activating mTOR in POMC
neurons.
Glucose intolerance and diabetes are commonly associated
with obesity (Mokdad et al., 2001). Paradoxically, we did not
observe such a deleterious metabolic dysfunction in Pomc-
cre;Tsc1-f/f mice, despite the fact that they were obese and
hyperphagic. Instead, these mice had an improved glucose
tolerance (Figure 4J). Interestingly, a recent study has also re-
vealed that direct leptin action in POMC neurons regulates
glucose homeostasis independent of body weight (Berglund
et al., 2012). Other than regulating body weight and appetite,
the arcuate nucleus is well documented as a central regulator
for glucose homeostasis. To keep a constant glucose supply
to the brain, those hypothalamic neurons that are located
outside the blood-brain barrier can monitor the glucose level in
the periphery and send feedback commands to visceral organs
such as the liver and pancreas through the descending auto-
nomic system to counterbalance any fluctuation of the glucose
supply to the brain (Parton et al., 2007). Moreover, activating
KATP channels in hypothalamic neurons has been shown to
improve glucose metabolism as infusing diazoxide to the third
ventricle suppresses hepatic gluconeogenesis (Pocai et al.,
2005) and central GLP-1 reduces peripheral glucose levels by
activating KATP channels in POMC neurons (Sandoval et al.,
2008). As obesity impairs glucose tolerance, we suspect that
the improved glucose tolerance in the Pomc-cre;Tsc1-f/f mice
might be more significant in pair-feeding experiments that
ensure matched body weight.
Previous study has shown that conditional knockout of
Phosphatase and Tensin Homolog (PTEN), a lipid phosphatase
that antagonizes the function of PI3K, in POMC neurons causes
hyperphagic obesity, raising the possibility that removal of
PTEN results in an increase of PIP3, which could interact with
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(Plum et al., 2006). In our study, we found that elevated mTOR
signaling in POMC neurons increased KATP current, and this
heightened KATP channel activity silenced POMC neurons and
reduced leptin-stimulated a-MSH secretion; Pomc-cre;Tsc1-f/f
mice also exhibited a hyperphagic obese phenotype (Figures 4
and 5). Since increasing PIP3 level on the plasma membrane
activates PI3K, a canonical activator of mTOR (Wullschleger
et al., 2006), it is expected that deleting PTEN in POMC neurons
may also activate mTOR, and this elevated mTOR activity could
activate KATP channels, as we have shown in our study. Whereas
deleting PTEN increases plasma PIP3 thereby prolonging the
opening time of KATP channels (Plum et al., 2006), the elevated
mTOR signaling in POMC neurons lacking TSC1 likely causes
an increase in KATP channel density, because the maximum
KATP current level is doubled in the presence of diazoxide (Fig-
ure 4I). Since PIP3 and diazoxide share the same common
mechanism for KATP channel activation due to increased open
time (Koster et al., 1999), the maximum KATP current in POMC
neurons without TSC1 should remain unchanged if activating
mTOR were to increase KATP current by generating PIP3. It is
of interest to note that deleting PTEN in POMC neurons also
results in hypertrophic soma as in POMC neurons with an
elevated mTOR activity (Mori et al., 2009). It thus seems likely
that activation of the PI3K pathway will have effects similar
to those caused by elevating mTOR activity, likely an in-
crease of KATP channel density, in addition to an increase of
channel open time due to an increase of phosphoinositides
such as PIP3.
Rapamycin has been found to affect the expression of Kv1.1
and Kv4.2 in dendrites of hippocampal neurons (Lee et al.,
2011; Raab-Graham et al., 2006). Here we provide another
example of how mTOR regulates neuronal activity by controlling
ion channel density. Under physiological conditions, the ion
channel density in neurons is tightly regulated (Ma and Jan,
2002). For example, when Parton et al. (2007) expressed in trans-
genic mice a mutant form of Kir6.2 under the POMC promoter,
POMC neurons in these transgenic mice nonetheless exhibit
normal levels of KATP channel density (Parton et al., 2007). Ion
channel density may be controlled at several different levels
including transcription, translation, trafficking, and quality
control of the endoplasmic reticulum (ER) (Ma et al., 2001). We
found that POMC neurons from old mice express the transcripts
for KATP channel subunits Kir6.2 and SUR1, for the most
common KATP channel composition in neurons (van den Top
et al., 2007). As functional KATP requires the coassembly of
Kir6.2 and SUR1 (Schwappach et al., 2000; Zerangue et al.,
1999), the upregulation of Kir6.2 in POMC neurons in older
mice is likely to increase the expression of KATP channels,
leading to hyperpolarization and neuronal silencing (Figure 2).
Moreover, constitutive mTOR activation that results in excessive
protein translation could lead to ER stress (Reiling and Sabatini,
2006), and ER stress may silence brain endothelial cells by
increasing the activity of Kir2.1 channels (Kito et al., 2011). In-
terestingly, multi-unit recording in the hypothalamic supra-
chiasmatic nucleus of aging rats has revealed a reduction in
the amplitude of the electrical rhythm (Nakamura et al., 2011).
The aging process has also been shown to modulate ion chan-nels such as the expression of Kv1.1 and Kv1.2 in Purkinje
neurons (Zhang et al., 2010). It would be of interest to test in
future studies whether the age-dependent elevation of mTOR
signaling causes ER stress in POMC neurons, and if ER stress
or other aspects of mTOR signaling would unleash KATP channel
trafficking or in some other ways increase KATP channel density,
and ultimately reduce POMC neuron excitability.
We have shown that inhibiting mTOR by infusing rapamycin
can promote POMC neuronal projections to their target
region, the PVN (Figure 7). POMC neurons exert their anorexi-
genic effects on neurons expressing melanocortin 4 receptor
(MC4R), a mandatory receptor for mediating the a-MSH effect
in vivo (Vaisse et al., 1998). The expansion of POMC neuronal
projection to the PVN with MC4R expression is likely one of
the mechanisms for rapamycin to reduce midlife obesity.
Multiple studies have revealed the impact of mTOR signaling
on neuronal morphology. For example, rapamycin injection
restores axon projection in Pomc-cre;Tsc1-f/f mice (Mori et al.,
2009). Other studies have shown that the AKT-TSC-mTOR
pathway plays a pivotal role in axon/dendrite polarity, axon/
dendrite growth and projection (Choi et al., 2008). Activating
mTOR by the AKT-TSC pathway upregulates SAD kinase,
a kinase that determines the fate of neurite development by
phosphorylating tau protein (Kishi et al., 2005; Wildonger et al.,
2008). In the visual system of fruit flies, increased TSC-TOR
signaling cell autonomously affects photoreceptor axon guid-
ance (Knox et al., 2007). Recent study also has shown that
deleting the autophagy gene 7 (Atg7) in POMC neurons reduces
neurite projection to the PVN (Coupe´ and Bouret, 2012). Interest-
ingly, Atg7 is inhibited by mTOR (Wyttenbach et al., 2008).
Hence, the elevated mTOR signaling in POMC neurons of aged
mice may suppress Atg7 and reduce neurite projection. Another
study has found that deleting the LKB1 kinase, another sup-
pressor of mTOR, in POMC neurons also reduces POMC
neuronal projections to the PVN (Claret et al., 2011). Interest-
ingly, aging is associated with numerous alterations of neuronal
morphology, such as the hypertrophic soma of projection
neurons with impoverished neuropiles in the limbic system
(Machado-Salas and Scheibel, 1979) and the disruption of
synaptic circuits of olfactory sensory neurons (Richard et al.,
2010). Another fertile ground for future studies would be the
age dependence of neuronal morphology regulation.
In summary, our study has demonstrated an important role of
mTOR signaling in POMC neurons in developing age-dependent
obesity. Upregulation of mTOR signaling in the hypothalamic
POMC neurons causes an increase of KATP channel activity to
silence POMC neurons and reduce their anorexigenic output,
by suppressing leptin-stimulated a-MSH secretion and by
reducing POMC neuronal projections to the target regions (Fig-
ure 8). Moreover, rapamycin may provide beneficial effects on
aging-related metabolic disorders, by reducing midlife obesity.EXPERIMENTAL PROCEDURES
Animals
This study was approved by the IACUC of the UCSF. At least three animals
were used for every single experiment. Details about the mouse strain origins
and drug preparation are described in the Supplemental Information.Neuron 75, 425–436, August 9, 2012 ª2012 Elsevier Inc. 433
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A brain infusion kit (Alzet) was implanted into the right lateral ventricle attached
to an osmotic minipump (Model1004 osmotic pump, Alzet). Minipumps and
tubing was filled with rapamycin (10 mg/ml) or vehicle only (60% PEG400,
30% cremaphor and 10% DMSO). Detailed procedures are described in the
Supplemental Information.
Intraperitoneal Glucose Tolerance Test
Experimental procedure for intraperitoneal glucose tolerance test is described
in the Supplemental Information.
Electrophysiology
Brain slices (250 mm thick) containing arcuate nucleus were prepared as
described previously (Sternson et al., 2005). KATP currents in POMC neurons
weremeasured as the glibenclamide-sensitive slope conductance of a voltage
ramp as described previously (Plum et al., 2006; Speier et al., 2005). Briefly,
POMC neurons were dialyzed with the same intracellular solution with low
Mg2ATP and simultaneously the slices were perfused with diazoxide (Sigma)
for ten minutes, and then glibenclamide was added to block KATP currents.
Detailed experimental procedures are described in the Supplemental
Information.
Single cell RT-PCR: cDNA synthesis single-cell PCR were prepared as
described earlier (Liss et al., 1999). An RT-PCR kit (Superscript III, Invitrogen)
was used to generate first strain cDNA using random hexamers and the cDNA
library for each sample was used for multiplex PCR and nested PCR. Primer
sequences were adapted as described earlier (Liss et al., 1999; Price et al.,
2008).
Ex Vivo a-MSH Secretion Assay
The hypothalamic explants containing the arcuate nucleus were incubated for
45 min in 250 ml aCSF then transferred to solutions containing 50 nM leptin
(Sigma) or 50 nM leptin plus 10 mM glibenclamide. At the end of each period,
the aCSF was frozen until it was assayed for a-MSH by a fluorescent immuno-
assay (Phoenix Pharmaceuticals). Detailed experimental procedures are
described in the Supplemental Information.
Immunostaining
Brain sections (20 mm) were stained with primary antibodies against GFP
(chicken 1:200, Aves) and phospho-S6 (rabbit, 1:200, Cell Signaling) followed
by Alexa dye-tagged secondary antibodies (donkey 1:500, Invitrogen). See
Supplemental Information for detailed experimental procedures.
Statistical Analysis
Statistical analyses were performed with Prism software (Graphpad Software)
using the Fisher’s exact test, one-way ANOVA or two-way repeated-measures
ANOVA with Bonferroni post hoc multicomparison test and Student’s t test for
pair-wise comparisons. p < 0.05 was considered statistically significant. GFP-
positive neurite densities within the PVN region were first converted to binary
file then further quantified by Image J (NIH).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.neuron.2012.03.043.
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